Biologic drugs induced vitiligo: case reports and review of literature

Biological drugs are extensively used to treat various inflammatory diseases, including psoriasis, atopic dermatitis (AD), and rheumatoid arthritis. While generally effective and safe, these therapies have been increasingly associated with secondary development of vitiligo, especially with anti-TNF...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in immunology Vol. 15; p. 1455050
Main Authors:	Shao, Xinyi, Chen, Tingqiao, Pan, Xingyu, Chen, Shuang, Chen, Yangmei, Chen, Jin
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media SA 17.12.2024 Frontiers Media S.A
Subjects:	Adolescent Aged, 80 and over Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Atopic dermatitis Biological products Biological Products - adverse effects Biological Products - therapeutic use biological therapy Case reports Crohn's disease cytokine imbalance Dermatitis Dermatitis, Atopic - drug therapy Drug development Drug dosages dupilumab-induced vitiligo Erythema Female Females Fungal infections Helper cells Homeostasis Humans Immunology Inflammatory diseases inflammatory skin diseases Legs Literature reviews Lymphocytes T Male Patients Psoriasis Rheumatoid arthritis Steroids Tumor necrosis factor Vitiligo Vitiligo - chemically induced atopic dermatitis inflammatory skin diseases dupilumab-induced vitiligo biological therapy cytokine imbalance
ISSN:	1664-3224, 1664-3224
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!